BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31017300)

  • 1. Development and validation of a simple and sensitive high-resolution LC/MS method for determination of PF-04620110 in dog plasma: Application to a pharmacokinetic study.
    He F; Zheng W; Chen Y; Mo C; Chen Y
    Biomed Chromatogr; 2019 Sep; 33(9):e4562. PubMed ID: 31017300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of PF-04620110, a novel inhibitor of diacylglycerol acyltransferase-1, in rat plasma using liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic studies.
    Lee KR; Choi SH; Song JS; Seo H; Chae YJ; Cho HE; Ahn JH; Ahn SH; Bae MA
    Biomed Chromatogr; 2013 Jul; 27(7):846-52. PubMed ID: 23420715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, bioavailability and metabolism of scopoletin in dog by ultra-high-performance liquid chromatography combined with linear ion trap-Orbitrap tandem mass spectrometry.
    Zhao YX; Wang M; Dong WT; Li Y
    Biomed Chromatogr; 2019 Mar; 33(3):e4436. PubMed ID: 30421792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat.
    Li R; Ren M; Lu W; Yuan Y; Li J; Zhong W
    Biomed Chromatogr; 2021 Feb; 35(2):e4968. PubMed ID: 32881002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in dog plasma and its application to a pharmacokinetic study.
    Zhang T; Sun Y; Zhang P; Gao J; Wang S; He Z
    Biomed Chromatogr; 2013 Feb; 27(2):137-41. PubMed ID: 22736298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated LC-MS/MS method for the determination of senkyunolide I in dog plasma and its application to a pharmacokinetic and bioavailability studies.
    Li JQ; Wang JF; Li J; Zhang SH; He D; Tong RS; She SY
    Biomed Chromatogr; 2018 May; 32(5):e4182. PubMed ID: 29314089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and bioavailability study of kurarinone in dog plasma by UHPLC-MS/MS.
    Huang Y; Lin H; Chen Y; Huang X
    Biomed Chromatogr; 2020 Nov; 34(11):e4945. PubMed ID: 32656774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-high-performance liquid chromatography tandem mass spectrometry method for the determination of gambogenic acid in dog plasma and its application to a pharmacokinetic study.
    Chen JP; Wang DL; Yang LL; Wang CY; Wang SS
    Biomed Chromatogr; 2014 Dec; 28(12):1854-9. PubMed ID: 24802389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated LC-MS/MS method for the quantification of capivasertib in dog plasma: Application to its pharmacokinetics study.
    Zhang Z; Nong L; Chen ML; Liu MH; Cheng WW
    Biomed Chromatogr; 2020 Oct; 34(10):e4920. PubMed ID: 32537750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of a astragaloside IV derivative LS-102 in plasma by ultra-performance liquid chromatography-tandem mass spectrometry in dog plasma and its application in a pharmacokinetic study.
    Sun WX; Zhang ZF; Xie J; He Y; Cheng Y; Ding LS; Luo P; Qing LS
    Phytomedicine; 2019 Feb; 53():243-251. PubMed ID: 30668404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cligosiban in dog plasma after oral administration by liquid chromatography electrospray ionization tandem mass spectrometry.
    Xi W; Zou Q; Ouyang P
    Biomed Chromatogr; 2019 Oct; 33(10):e4611. PubMed ID: 31145820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination and pharmacokinetic studies of arecoline in dog plasma by liquid chromatography-tandem mass spectrometry.
    Li B; Zhou XZ; Li JY; Yang YJ; Niu JR; Wei XJ; Liu XW; Li JS; Zhang JY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():12-8. PubMed ID: 25140901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of idelalisib and its metabolite GS-563117 in dog plasma by LC-MS/MS: Application to a pharmacokinetic study.
    Wang C; Jia F; Zhang Y
    Biomed Chromatogr; 2019 May; 33(5):e4511. PubMed ID: 30773664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of ipatasertib in dog plasma using LC/MS/MS.
    Liu Y; Ma C; Jiao W; Yang Y; Zhang H; Du L; Ma M; Sun P; Li X; Chen J
    Biomed Chromatogr; 2020 Oct; 34(10):e4923. PubMed ID: 32558944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of kurarinone in rat plasma by UPLC-MS/MS.
    Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug-drug interaction study.
    Liu J; Liu H; Zeng Q
    Biomed Chromatogr; 2019 May; 33(5):e4507. PubMed ID: 30754071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs.
    Choi HI; Kim T; Lee SW; Woo Kim J; Ju Noh Y; Kim GY; Jin Park H; Chae YJ; Lee KR; Kim SJ; Koo TS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122862. PubMed ID: 34332199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and sensitive ultra-high performance liquid chromatography tandem mass spectrometry method for the quantitative analysis of VX-548 in monkey plasma: Method validation and application to pharmacokinetic study.
    Zhang H; Chen Y; Huang J; Sun W
    Biomed Chromatogr; 2024 Jul; 38(7):e5907. PubMed ID: 38783548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of anĀ UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study.
    Wang MJ; Zhao YH; Fan C; Wang YJ; Wang XQ; Qiu XJ; Shen RL
    Drug Des Devel Ther; 2021; 15():4167-4175. PubMed ID: 34629864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.